The beneficial effects of ETS-GS, a novel Vitamin E derivative, on a rat model of crush injury

Shock

Volumn 46, Issue 6, 2016, Pages 681-687

  Nakagawa, Junichiro ^a   Matsumoto, Naoya ^a   Nakane, Yuko ^b   Yamakawa, Kazuma ^a   Yamada, Tomoki ^a   Matsumoto, Hisatake ^a   Shimazaki, Junya ^a   Imamura, Yukio ^a   Ogura, Hiroshi ^a   Jin, Takashi ^a   Shimazu, Takeshi ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b RIKEN   (Japan)

Author keywords

Acute lung injury; crush syndrome; oxidative stress; reactive oxygen species; reperfusion injury; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL DERIVATIVE; ANTIOXIDANT; ETS GS; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; MALONALDEHYDE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; ALPHA TOCOPHEROL; GAMMA-L-GLUTAMYL-S-(2-(((3,4-DIHYDRO-2,5,7,8-TETRAMETHYL-2-(4,8,12- TRIMETHYLTRIDECYL)-2H-1-BENZOPYRAN-6-YL)OXY)CARBONYL)-3-OXO-3-((2-SULFOETHYL)AMINO)PROPYL)-L-CYSTEINYLGLYCINE SODIUM SALT; OLIGOPEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CELL INFILTRATION; CELL NUCLEUS; CONTROLLED STUDY; CRUSH SYNDROME; CRUSH TRAUMA; CYTOPLASM; EX VIVO STUDY; LUNG EDEMA; LUNG HEMORRHAGE; MALE; NONHUMAN; PATHOGENESIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; SURVIVAL RATE; UPREGULATION; ANALOGS AND DERIVATIVES; ANIMAL; BLOOD; DISEASE MODEL; DRUG EFFECTS; LUNG; METABOLISM; PATHOLOGY; WISTAR RAT;

ANIMALS; CRUSH SYNDROME; DISEASE MODELS, ANIMAL; HMGB1 PROTEIN; INTERLEUKIN-6; LUNG; MALE; MALONDIALDEHYDE; OLIGOPEPTIDES; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE; VITAMIN E;

EID: 84976353321     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0000000000000681     Document Type: Article

References (32)

1. Oda J, Tanaka H, Yoshioka T, Iwai A, Yamamura H, Ishikawa K, Matsuoka T, Kuwagata Y, Hiraide A, Shimazu T, et al.: Analysis of 372 patients with Crush syndrome caused by the Hanshin-Awaji earthquake. J Trauma 42(3):470-475, 1997.
2. Vanholder R, van der Tol A, De Smet M, Hoste E, Koc M, Hussain A, Khan S, Sever MS: Earthquakes and crush syndrome casualties: Lessons learned from the Kashmir disaster. Kidney Int 71(1):17-23, 2007.
3. Erek E, Sever MS, Serdengeçti K, Vanholder R, Akoǧlu E, Yavuz M, Ergin H, Tekçe M, Duman N, Lameire N: Turkish Study Group of Disaster: An overview of morbidity and mortality in patients with acute renal failure due to crush syndrome: The Marmara earthquake experience. Nephrol Dial Transplant 17(1):33-40, 2002.
4. Zhang L, Fu P, Wang L, Cai G, Chen D, Guo D, Sun X, Chen F, Bi W, Zeng X, et al.: The clinical features and outcome of crush patients with acute kidney injury after theWenchuan earthquake: Differences between elderly and younger adults. Injury 43(9):1470-1475, 2012.
5. Hatamizadeh P, Najafi I, Vanholder R, Rashid-Farokhi F, Sanadgol H, Seyrafian S, Mooraki A, Atabak S, Samimagham H, Pourfarziani V, et al.: Epidemiologic aspects of the Bam earthquake in Iran: The nephrologic perspective. Am J Kidney Dis 47(3):428-438, 2006.
6. Odeh M: The role of reperfusion-induced injury in the pathogenesis of the crush syndrome. N Engl J Med 324(20):1417-1422, 1991.
7. Akimau P, Yoshiya K, Hosotsubo H, Takakuwa T, Tanaka H, Sugimoto H: New experimental model of crush injury of the hindlimbs in rats. J Trauma 58(1): 51-58, 2005.
8. Mohri T, Tanaka H, Tajima G, Kajino K, Sonoi H, Hosotsubo H, Ogura H, Kuwagata Y, Shimazu T, Sugimoto H: Synergistic effects of recombinant human soluble thrombomodulin and fluid-volume resuscitation in a rat lethal crush injury model. Shock 26(6):581-586, 2006.
9. Sonoi H, Matsumoto N, Ogura H, Hosotsubo H, Noguchi K, Kuwagata Y, Sugimoto H: The effect of antithrombin on pulmonary endothelial damage induced by crush injury. Shock 32(6):593-600, 2009.
10. Shimazaki J, Matsumoto N, Ogura H, Muroya T, Kuwagata Y, Nakagawa J, Yamakawa K, Hosotsubo H, Imamura Y, Shimazu T: Systemic involvement of high-mobility group box 1 protein and therapeutic effect of anti-high-mobility group box 1 protein antibody in a rat model of crush injury. Shock 37(6): 634-638, 2012.
11. López Farré A, Casado S: Heart failure, redox alterations, and endothelial dysfunction. Hypertension 38(6):1400-1405, 2001.
12. Canãs PE: The role of xanthine oxidase and the effects of antioxidants in ischemia reperfusion cell injury. Acta Physiol Pharmacol Ther Latinoam 49(1):13-20, 1999.
13. Tang D, Kang R, Zeh HJ 3rd, Lotze M: High-mobility group box 1, oxidative stress, and disease. Antioxid Redox Signal 14(7):1315-1335, 2011.
14. Tang D, Shi Y, Kang R, Li T, Xiao W, Wang H, Xiao X: Hydrogen peroxide stimulates macrophages and monocytes to actively release HMGB1. J Leukoc Biol 81(3):741-747, 2007.
15. Hagiwara S, Koga H, Iwasaka H, Kusaka J, Uchida T, Goto K, Yokoi I, Noguchi T: ETS-GS, a new anti-oxidative drug, protects against lipopolysaccharideinduced acute lung and liver injury. J Surgical Res 171(2):734-741, 2011.
16. Koga H, Hagiwara S, InomataM, Kono Y, Oyama Y, Kai S, Nishida T, Noguchi T: The newvitamin E derivative, ETS-GS, protects against cecal ligation and punctureinduced systemic inflammation in rats. Inflammation 35(2):545-553, 2012.
17. Koga H, Hagiwara S, InomataM, Kusaka J, Asai N, OyamaM, Kita K, Kashima K, Yokoi I, Noguchi T: Vitamin E derivative ETS-GS reduces liver ischemiareperfusion injury in rats. J Surg Res 175(1):118-122, 2012.
18. Hagiwara S, Koga H, Iwasaka H, Kudo K, Hasegawa A, Kusaka J, Yokoi I, Noguchi T: ETS-GS, a new antioxidant, ameliorates renal ischemia-reperfusion injury in a rodent model. J Surgical Res 171(1):226-233, 2011.
19. Li HB,Wang GZ, Gong J,Wu ZY, Guo S, Li B, Liu M, Ji YD, Tang M, Yuan SY, et al.: BML-111 attenuates hemorrhagic shock-induced acute lung injury through inhibiting activation of mitogen-activated protein kinase pathway in rats. J Surg Res 183(2):710-719, 2013.
20. Matute-Bello G, Downey G, Moore BB, Groshong SD, Matthay MA, Slutsky AS, Kuebler WM: Acute lung injury in animals study group: An official American Thoracic Society workshop report: Features and measurements of experimental acute lung injury in animals. Am J Respir Cell Mol Biol 44(5):725-738, 2011.
21. Melotti P, Nicolis E, Tamanini A, Rolfini R, Pavirani A, Cabrini G: Activation of NF-kB mediates ICAM-1 in respiratory cells exposed to an adenovirus-derived vector. Gene Ther 8(18):1436-1442, 2001.
22. Fan Z, Yao J, Li Y, Hu X, Shao H, Tian X: Anti-inflammatory and antioxidant effects of curcumin on acute lung injury in a rodent model of intestinal ischemia reperfusion by inhibiting the pathway of NF-Kb. Int J Clin Exp Pathol 8(4):3451-3459, 2015.
23. Bergamini CM, Gambetti S, Dondi A, Cervellati C: Oxygen, reactive oxygen species and tissue damage. Curr Pharm Des 10(14):1611-1626, 2004.
24. Cuzzocrea S, Riley DP, Caputi AP, Salvemini D: Antioxidant therapy: A new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacol Rev 53(1):135-159, 2001.
25. Eltzschig HK, Eckle T: Ischemia and reperfusion from mechanism to translation. Nat Med 17(11):1391-1401, 2011.
26. Swindle EJ,Metcalfe DD: The role of reactive oxygen species and nitric oxide in mast cell-dependent inflammatory processes. Immunol Rev 217:186-205, 2007.
27. Thannickal VJ, Fanburg BL: Reactive oxygen species in cell signaling. Am J Physiol Lung Cell Mol Physiol 279(6):L1005-L1028, 2000.
28. Del Rio D, Stewart AJ, Pellegrini N: A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutr Metab Cardiovasc Dis 15(4):316-328, 2005.
29. Valko M, Izakovic M, Mazur M, Rhodes CJ, Telser J: Role of oxygen radicals in DNA damage and cancer incidence. Mol Cell Biochem 266(1-2):37-56, 2004.
30. Sakamoto W, Fujie K, Handa H, Ogihawa T, Mino M: In vivo inhibition of superoxide production and protein kinase C activity in macrophages from vitamin E-treated rats. Int J Vitam Nutr Res 60(4):338-342, 1990.
31. Morgan MJ, Liu ZG: Crosstalk of reactive oxygen species and NF-kappaB signaling. Cell Res 21(1):103-115, 2011.
32. Sims GP, Rowe DC, Rietdijk ST, Herbst R, Coyle AJ: HMGB1 and RAGE in inflammation and cancer. Annu Rev Immunol 28:367-388, 2010.